News & Insights

Oxford Technology & Innovations EIS Fund (OTIF) invests £230k into University of Oxford spinout company Oxford Endovascular Ltd

  • Oxford Endovascular Ltd is commercialising OxiFlow™, a novel blood flow diversion device (‘stent’) for treating Intracranial Aneurysms (ICAs).
  • OTIF’s investment was advised by Oxford Investment Consultants LLP and was part of a $10m Series A funding round led by Vulpes Investment Management, a Singapore-based life sciences investor.
  • This is the second OTIF investment in Oxford Endovascular to date, bringing total funds invested by the fund in the Company to £500k.
Read post

OTIF Tranche 12 Launched!

We’re excited to announce the launch of the first 2021 round of the Oxford Technology and Innovations EIS Fund (OTIF) advised by us and managed by Thompson Taraz!

Read post